
IDBI Bank to be first off disinvestment block, followed by stake sales in other PSUs in Q4
The move is aimed at avoiding market crowding and ensuring sufficient investor appetite.
The IDBI Bank transaction is expected to fetch about ₹50,000 crore for the central government and Life Insurance Corporation of India, which together hold over 94% in the bank, the people said. The key stakeholders plan to divest a 60.72% stake in the lender.
There has been no major asset monetisation or stake sale in the first quarter and the second quarter could also remain subdued, the first person said.
"While the stake sale in IDBI Bank is likely to fetch about ₹50,000 crore, another ₹10,000-15,000 crore could come from offers for sale of equity in other listed public sector undertakings," the first person added.
The Centre is currently in the final stages of divestment in IDBI Bank. An inter-ministerial group has approved the share purchase agreement detailing the terms of the sale, paving the way for the government to invite financial bids, the second person said, asking not to be identified.
"The proposal will be discussed by the core group of secretaries on disinvestment for clearance, after which financial bids are likely to be invited in September-October, following which financial bids will be invited," the second person added.
The potential suitors for the IDBI Bank stake include Fairfax India Holdings (promoter of CSB Bank), Emirates NBD, and Kotak Mahindra Bank.
Transaction timeline
Both people aware of the stake sale plan said the timeline for the transaction remains broadly on track. The IDBI Bank privatisation plan was first announced in the Union Budget for FY22 but had been delayed multiple times during the past three years.
IDBI Bank shares climbed 2% to ₹97.10 on the BSE as of 10:33 AM on Wednesday, extending this year's gains to about 27%. The lender's market capitalisation exceeds ₹1 trillion.
The Centre stopped setting separate disinvestment targets in FY24. However, the budget estimate for miscellaneous capital receipts (MCR), which includes proceeds from equity sales and public asset management, is pegged at ₹47,000 crore for FY26. For FY25, the receipts were revised to ₹33,000 crore from ₹50,000 crore pegged in the budget estimate.
Mint reported earlier that there were as many as eight strategic disinvestment plans at various stages, including stake sales in BEML Ltd, Shipping Corp. of India Ltd, HLL Lifecare Ltd, Projects & Development India Ltd, and Indian Medicines Pharmaceutical Corp. Ltd.
Little progress has been made on divesting stake in most of these companies and they could be taken up in the coming quarters, depending on market conditions.
'Some of the planned divestments will be taken up once the IDBI Bank sale is completed. That said, the Centre is confident of exceeding the ₹47,000 crore MCR target for FY26, buoyed by the IDBI transaction and other stake sales," the first person said. "Divestment proceeds in FY26 are expected to reach a multi-year high."
The Centre's disinvestment receipts touched a record of over ₹1 trillion crore in FY18, largely due to the stake sale in Hindustan Petroleum Corporation Ltd and the listing of central public sector enterprises. The government sold its entire 51.1% stake in HPCL to Oil and Natural Gas Corporation for ₹36,915 crore.
Disinvestment proceeds stood at ₹84,972 crore in FY19 and ₹50,300 crore in FY20, according to data from the Department of Investment and Public Asset Management.
A finance ministry spokesperson did not respond to an emailed query. Spokespersons for Fairfax India Holdings, Emirates NBD, and Kotak Mahindra Bank did not respond to requests for comment.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Mint
an hour ago
- Mint
Upcoming IPO: Ashish Kacholia-owned Sahajanand Medical Technologies files DRHP for public issue launch
Upcoming IPO: Medical devices company Sahajanand Medical Technologies has filed its draft red herring prospectus (DRHP) with the capital markets regulator, the Securities and Exchange Board of India (Sebi), on Friday, July 25, 2025. Founded by Dhirajlal Kotadia in 2001, Sahajanand Medical Technologies (SMT) Limited specialises in advanced medical devices in vascular and structural heart intervention. Ashish Kacholia, Samara Capital Markets Holding Limited, Kotak Pre-IPO Opportunities Fund and Plutus Wealth Management LLP are the major shareholders in the company. According to the DRHP filing, the company is offering a book-built initial public offering (IPO) with an entirely offer for sale (OFS) component. The company proposed to make an offer-for-sale of up to 2,76,44,231 equity shares to shareholders with a face value of Re 1 apiece. The offer also provides a discounted subscription reservation for eligible employees within the employee reservation section. The public issue consists of stakes of up to 27,00,000 equity shares each of Shree Hari Trust and Dhirajkumar Savjibhai Vasoya, around 1,29,58,126 equity shares by Samara Capital Markets Holding Limited, up to 26,15,750 equity shares by Kotak Pre-IPO Opportunities Fund, and up to 66,70,355 equity shares by NHPEA Sparkle Holding B.V. The offer is conducted through a book-building process, with up to 50% allocated to qualified institutional buyers and at least 15% and 35% assigned to non-institutional and retail individual bidders, respectively, according to the draft papers. The equity shares are proposed to be listed on the NSE and BSE. The book-running lead managers for the public issue are Motilal Oswal Investment Advisors, Avendus Capital Private, HSBC Securities and Capital Markets (India), and Nuvama Wealth Management. MUFG Intime India is the registrar. Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions, as market conditions can change rapidly, and circumstances may vary.


Business Standard
2 hours ago
- Business Standard
Reliance Infra reports turnaround Q1 PAT to Rs 60 cr
Reliance Infrastructure reported a consolidated net profit of Rs 59.84 crore in Q1 FY26, compared to a net loss of Rs 233.74 crore posted in Q1 FY25. Revenue from operations fell 17.86% to Rs 5,907.82 crore in the quarter ended 30 June 2025. Total expenses declined 4.84% to Rs 6,469.81 crore in Q1 FY26 over Q1 FY25. During the quarter, the cost of power purchased stood at Rs 4,360.23 crore (down 8.12% YoY), while employee benefits expense was Rs 297.90 crore (up 5.97% YoY). The company reported a profit before exceptional items and tax of Rs 286.67 crore in Q1 FY26, compared to a pre-tax loss of Rs 78.29 crore reported in the same quarter of the previous year. The company reported exceptional items of Rs 0.62 crore in Q1 FY26. EBITDA stood at Rs 1,494 crore in Q1 FY26, registering a 29% YoY growth compared to Rs 1,155 crore in Q1 FY25. Reliance Infrastructure is one of the largest infrastructure companies, developing projects through various Special Purpose Vehicles (SPVs) across several high-growth sectors such as power, roads, and metro rail in the infrastructure space, as well as in the defence sector. It is also a major player in providing Engineering and Construction (E&C) services for power, infrastructure, metro, and road projects. The scrip hit a 5% lower circuit and closed at Rs 342.05 on Friday, 25 July 2025, on the BSE.


Business Standard
2 hours ago
- Business Standard
Chennai Petro posts net loss of Rs 57 crore in Q1; clocks GRM of $3.22 per barrel
Chennai Petroleum Corporation (CPCL) has reported a standalone net loss of Rs 57 crore in Q1 FY26 as compared with net profit of Rs 343 crore recorded in Q1 FY25. For the quarter ended on 30 June 2025, revenue from operations stood at Rs 18,683 crore, down 8.24% YoY. The company posted a pre-tax profit of Rs 80 crore in Q1 FY26 as against a pre-tax profit of Rs 470 crore registered in Q1 FY25. The gross refining margin (GRM) for the quarter was $3.22 per barrel, down from $6.33 per barrel in the corresponding period last year. This decline was primarily due to inventory losses on crude oil and finished products of US$ 1.9 per barrel as against inventory gain of US$ 1.1 per barrel in Q1 of the previous financial year. CPCL has recorded a crude throughput of 2.981 million metric tonnes (MMT) for the quarter ended 30 June 2025, as compared to 2.830 MMT in the corresponding quarter of the previous financial year, with a capacity utilisation of 114%. This was further supported by best-ever distillate yield of about 80% and excellent performance on energy front, demonstrating continued operational efficiency. On a consolidated basis, CPCL has posted a net loss of Rs 40 crore in Q1 FY2025-26 as against a net profit of Rs 357 crore. Net sales declined by 13.4% YoY to Rs 14,812.23 crore during the period under review. Chennai Petroleum Corporation is in the business of refining crude oil to produce & supply various petroleum products and manufacture and sell lubricating oil additives. The scrip tumbled 9.68% to end at Rs 687.35 on the BSE yesterday.